Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans De Winter

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 13, 2019
Efforts towards an On-Target Version of the Groebke-Blackburn-Bienaymé (GBB) Reaction for Discovery of Druglike Urokinase (uPA) InhibitorsRafaela Gladysz, Johannes Vrijdag, Dries Van Rompaey, et al.
Scientific Reports|December 10, 2017
Virtual screening for inhibitors of the human TSLP:TSLPR interactionDries Van Rompaey, Kenneth Verstraete, Frank Peelman, et al.
Scientific Reports|April 26, 2018
Author Correction: Virtual screening for inhibitors of the human TSLP:TSLPR interactionDries Van Rompaey, Kenneth Verstraete, Frank Peelman, et al.
European Journal of Medicinal Chemistry|July 3, 2025
Highly potent dipeptidyl peptidase 8/9 (DPP8/9) inhibitors designed via relative binding free energy calculationsVanesa Nozal, Olivier Beyens, Sarah Peeters, et al.
Chemmedchem|November 18, 2024
An Interdisciplinary Approach Provides Insights into the Pronounced Selectivity of Compound 42 for DPP9Olivier Beyens, Sam Corthaut, Anne-Marie Lambeir, et al.
Chemmedchem|June 27, 2022
Vildagliptin-Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9-Specific LeadSiham Benramdane, Joni De Loose, Olivier Beyens, et al.
The Journal of Organic Chemistry|May 2, 1997
Synthesis and Conformational Study of 3-Hydroxy-4-(Hydroxymethyl)-1-Cyclohexanyl Purines and PyrimidinesYuris Maurinsh, Jan Schraml, Hans De Winter, et al.
Frontiers in Chemistry|April 24, 2023
From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitorsCamilla Scarpellini, Sophie Valembois, Kenneth Goossens, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2016
Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398Kevin K Ariën, Muthusamy Venkatraj, Johan Michiels, et al.
Journal of Chemical Information and Modeling|October 16, 2025
MolAgent: Biomolecular Property Estimation in the Agentic EraJose Carlos Gómez-Tamayo, Joris Tavernier, Roy Aerts, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 13, 2019
Efforts towards an On-Target Version of the Groebke-Blackburn-Bienaymé (GBB) Reaction for Discovery of Druglike Urokinase (uPA) InhibitorsRafaela Gladysz, Johannes Vrijdag, Dries Van Rompaey, et al.
Scientific Reports|December 10, 2017
Virtual screening for inhibitors of the human TSLP:TSLPR interactionDries Van Rompaey, Kenneth Verstraete, Frank Peelman, et al.
Scientific Reports|April 26, 2018
Author Correction: Virtual screening for inhibitors of the human TSLP:TSLPR interactionDries Van Rompaey, Kenneth Verstraete, Frank Peelman, et al.
European Journal of Medicinal Chemistry|July 3, 2025
Highly potent dipeptidyl peptidase 8/9 (DPP8/9) inhibitors designed via relative binding free energy calculationsVanesa Nozal, Olivier Beyens, Sarah Peeters, et al.
Chemmedchem|November 18, 2024
An Interdisciplinary Approach Provides Insights into the Pronounced Selectivity of Compound 42 for DPP9Olivier Beyens, Sam Corthaut, Anne-Marie Lambeir, et al.
Chemmedchem|June 27, 2022
Vildagliptin-Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9-Specific LeadSiham Benramdane, Joni De Loose, Olivier Beyens, et al.
The Journal of Organic Chemistry|May 2, 1997
Synthesis and Conformational Study of 3-Hydroxy-4-(Hydroxymethyl)-1-Cyclohexanyl Purines and PyrimidinesYuris Maurinsh, Jan Schraml, Hans De Winter, et al.
Frontiers in Chemistry|April 24, 2023
From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitorsCamilla Scarpellini, Sophie Valembois, Kenneth Goossens, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2016
Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398Kevin K Ariën, Muthusamy Venkatraj, Johan Michiels, et al.
Journal of Chemical Information and Modeling|October 16, 2025
MolAgent: Biomolecular Property Estimation in the Agentic EraJose Carlos Gómez-Tamayo, Joris Tavernier, Roy Aerts, et al.
Pageof 6